<code id='77552469CD'></code><style id='77552469CD'></style>
    • <acronym id='77552469CD'></acronym>
      <center id='77552469CD'><center id='77552469CD'><tfoot id='77552469CD'></tfoot></center><abbr id='77552469CD'><dir id='77552469CD'><tfoot id='77552469CD'></tfoot><noframes id='77552469CD'>

    • <optgroup id='77552469CD'><strike id='77552469CD'><sup id='77552469CD'></sup></strike><code id='77552469CD'></code></optgroup>
        1. <b id='77552469CD'><label id='77552469CD'><select id='77552469CD'><dt id='77552469CD'><span id='77552469CD'></span></dt></select></label></b><u id='77552469CD'></u>
          <i id='77552469CD'><strike id='77552469CD'><tt id='77552469CD'><pre id='77552469CD'></pre></tt></strike></i>

          entertainment

          entertainment

          author:explore    Page View:5261

          Can the FDA be too flexible? How do you test a mechanical womb? And who decides what’s good enough for patients in need?

          We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Lizzy Lawrence joins us to explain the promise of artificial wombs and the debate over how to ethically develop them. We also discuss a momentous upcoming meeting in which FDA will consider the thorny case of a potential medicine for ALS whose supporting evidence has polarized patients and physicians.

          advertisement

          For more on what we cover, here’s the latest on artificial womb technology; here’s more on the ALS debate; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

          Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

          And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

          advertisement

          focus

          Activists slam private health insurers over coverage restrictions
          Activists slam private health insurers over coverage restrictions

          ProtestorsoutsideAmerica'sHealthInsurancePlansheadquarters.CourtesyPeople'sActionWASHINGTON—Hun

          read more
          Readout Newsletter: Bristol, Sangamo, Gilead, and more
          Readout Newsletter: Bristol, Sangamo, Gilead, and more

          EricRisberg/APWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup togetourbiotechnewsl

          read more
          As demand for Covid shots wanes, Moderna seeks its next success
          As demand for Covid shots wanes, Moderna seeks its next success

          RubyWallauforSTATModernachairmanNoubarAfeyanexudedstarpowerearlierthismonthashecommandedthespotlight

          read more

          Lack of darker skin in textbooks, journals harms patients of color

          HyacinthEmpinado/STATWhendermatologistJennaLesterlearnedthatrashesonskinandtoeswereasymptomofCovid-1